HiFiBiO Therapeutics Closes $67 Million Series C Financing to Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune Disorders

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2zrq0MV
via IFTTT